Long-term outcomes of light chain amyloidosis patients receiving heart transplant.
https://t.co/Ofh5h1QguK
OHT is an option that programs need to offer for advanced AL cardiac Amyloidosis patients-At the intersection of many specialties. #AmyloidosisAL
Despite major advances in treatment, heart failure-related deaths continue to rise. Quentin R. Youmans, MD (@QuentinYoumans), contributes to a joint statement from the Heart Failure Society of America and the American Society for Preventive Cardiology that calls for a bold shift: integrating prevention across the entire spectrum of care. From early detection to advanced therapies, prevention must be prioritized at every stage. Learn more about this roadmap to reshape heart failure care: https://t.co/jleH7O08q9
GME day @HowardU! Today, HU graduates fully trained Cardiologists, Dentists, Dermatologists, Family Physicians, Internists, Surgeons, Psychiatrists, Pulmonologists, Endocrinologists, Neurologists, OBGYNs, & more. Warriors ready to fight #HealthCareDisparities on Day 1!✊🏾
Advances in the screening, diagnosis, and treatment of transthyretin amyloid cardiomyopathy: New insights and future directions
Latest review article with my colleagues Drs. Andrew Girard and Talal Asif
https://t.co/dCYZEECT29
Care involving a #heartfailure specialist during an admission for HF ➡️ increased rates of #GDMT, decreased diuretics, lower in-hospital and long-term mortality, especially in #HFrEF, although across all #LVEF. https://t.co/kPxLXZvrTy
#JACCHF#GDMTworks@_antocannata
“Little Nic Nic, Oh, the places you will go.”🥹💐
This morning I gave my culminating Chief OB/GYN Grand Rounds!!!! 💪🏾❤️✅ Thanking God for a path that continues to illuminate my purpose and my values, and being able to walk in that fully everyday.
100 Days ‘til GRADUATION! 👨🏾🎓